Two Sigma Advisers’s Myovant Sciences Ltd. MYOV Stock Holding History

Two Sigma Advisers’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-132,500	Closed	-$3.57M	–	2820
2022 Q4	$3.57M	Buy	+132,500	New	+$3.49M	0.01%	923
2021 Q2	–	Sell	-34,700	Closed	-$714K	–	2772
2021 Q1	$714K	Buy	+34,700	New	+$790K	﹤0.01%	1837
2020 Q3	–	Sell	-25,500	Closed	-$526K	–	2698
2020 Q2	$526K	Buy	25,500 +4,900	+24%	+$66.7K	﹤0.01%	1863
2020 Q1	$156K	Buy	+20,600	New	+$231K	﹤0.01%	2227
2019 Q4	–	Sell	-17,000	Closed	-$88K	–	2509
2019 Q3	$88K	Sell	17,000 -5,400	-24%	-$40.1K	﹤0.01%	2121
2019 Q2	$203K	Buy	+22,400	New	+$334K	﹤0.01%	2125

Other funds holding MYOV

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Two Sigma Advisers's MYOV Position: Q1 2023 in Review

Two Sigma Advisers sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 132,500 shares — an estimated $3.57M sold.

Two Sigma Advisers first reported a position in MYOV in Q2 2019 and held it in 6 quarters. The position peaked at $3.57M in Q4 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

Two Sigma Advisers reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
Two Sigma Advisers sold 132,500 Myovant Sciences Ltd. shares in Q1 2023, an estimated $3.57M.
Two Sigma Advisers first reported a position in Myovant Sciences Ltd. in Q2 2019 and held it in 6 quarters.
Two Sigma Advisers's Myovant Sciences Ltd. position peaked at $3.57M in Q4 2022.
2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Two Sigma Advisers's 13F filing for Q1 2023, filed 15 May 2023.